Wednesday, 30 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q3 FY26

Zensar Technologies Q3 FY26 Results: Net Profit ₹200 Cr, Up 25.0% YoY

Zensar Technologies Ltd reported net profit of ₹200 Cr (+25.0% YoY) for Q3 FY26.

Q3 FY26 at a glance · ₹ crore
MetricQ3 FY26Q2 FY26Q3 FY25
Other income63.149.130.7
Total income1494.01470.01356.0
Exceptional items25.40.00.0
Net profit200.0182.0160.0
Operating margin17.7%16.3%15.5%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+25.00%
Net profit, quarter on quarter+9.90%
Source

BSE results filing, NSE: ZENSARTECH. Figures extracted from the filing.

Read the filing ↗

Zensar Technologies Ltd: key numbers

Share price
₹428.05
Market cap
₹9,742 Cr
Revenue (annual)
₹5,687 Cr
Net profit (annual)
₹774.6 Cr
P/E (TTM)
12.6×Sector 21.4×
Promoter holding
48.99%-0.01% QoQ
FII holding
10.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zensar Technologies Ltd

All →
16:50 IST BSE
Credit Rating

Zensar Technologies Credit Rating

ICRA Limited has reaffirmed the credit rating of Zensar Technologies for its long-term and short-term fund/non-fund based bank facilities, totaling ₹191 Crore.

Value
₹191.0 Cr
09:40 IST BSE
Employee Stock Options

Zensar Technologies Employee Stock Options

Designated person Vijayasimha Alilughatta acquired 8,983 shares of Zensar Technologies through an ESOP exercise. The transaction is valued at ₹0.43 Crore.

Value
₹0.43 Cr
19:12 IST BSE
Employee Stock Options

Zensar Technologies Employee Stock Options

Zensar Technologies has allotted 25,691 equity shares to employees following the exercise of their vested ESOPs.

11:34 IST BSE
Other Announcement

Zensar Technologies Other Announcement

Zensar Technologies Ltd has filed its quarterly shareholding pattern for the period ended December 31, 2025, in compliance with regulatory requirements.

13:16 IST BSE
Merger & Restructuring

Zensar Technologies Merger & Restructuring

Zensar Technologies announced the completed merger of its US subsidiaries M3BI LLC and Bridgeview Life Sciences LLC into Zensar Technologies Inc. The mergers become effective September 1, 2026.

Execution
Effective September 1, 2026
14:14 IST BSE
Other Announcement

Zensar Technologies Other Announcement

Zensar Technologies Limited has received an independent ESG score of 74 from Crisil ESG Ratings & Analytics Limited, categorizing the company under 'Leadership' for FY2026.